ABBOTT LABORATORIES
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
ABT$109.93-3.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheet
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $8,522 | $7,616 |
| Investments, primarily bank time deposits and U.S. treasury bills | 417 | 351 |
| Trade receivables, less allowances of — 2025: $490; 2024: $439 | 7,929 | 6,925 |
| Inventories: | ||
| Finished products | 3,976 | 3,700 |
| Work in process | 904 | 840 |
| Materials | 1,608 | 1,654 |
| Total inventories | 6,488 | 6,194 |
| Other prepaid expenses and receivables | 2,640 | 2,570 |
| Total current assets | 25,996 | 23,656 |
| Investments | 918 | 886 |
| Property and equipment, at cost: | ||
| Land | 541 | 528 |
| Buildings | 4,543 | 4,207 |
| Equipment | 17,571 | 15,517 |
| Construction in progress | 2,567 | 2,488 |
| 25,222 | 22,740 | |
| Less: accumulated depreciation and amortization | 13,406 | 12,082 |
| Net property and equipment | 11,816 | 10,658 |
| Intangible assets, net of amortization | 5,526 | 6,647 |
| Goodwill | 24,035 | 23,108 |
| Deferred income taxes and other assets | 18,422 | 16,459 |
| $86,713 | $81,414 | |
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2025 | 2024 | |
| Liabilities and Shareholders’ Investment | ||
| Current liabilities: | ||
| Trade accounts payable | $4,240 | $4,195 |
| Salaries, wages, and commissions | 1,745 | 1,701 |
| Other accrued liabilities | 5,812 | 5,143 |
| Dividends payable | 1,097 | 1,024 |
| Income taxes payable | 569 | 594 |
| Current portion of long-term debt | 3,033 | 1,500 |
| Total current liabilities | 16,496 | 14,157 |
| Long-term debt | 9,896 | 12,625 |
| Post-employment obligations and other long-term liabilities | 7,550 | 6,731 |
| Commitments and contingencies | ||
| Shareholders’ investment: | ||
| Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued | — | — |
| Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2025: 1,996,795,525; 2024: 1,991,472,630 | 25,527 | 25,153 |
| Common shares held in treasury, at cost — Shares: 2025: 260,196,074; 2024: 259,774,639 | (17,177) | (16,844) |
| Earnings employed in the business | 49,781 | 47,261 |
| Accumulated other comprehensive income (loss) | (6,001) | (7,906) |
| Total Abbott Shareholders’ Investment | 52,130 | 47,664 |
| Noncontrolling interests in subsidiaries | 641 | 237 |
| Total Shareholders’ Investment | 52,771 | 47,901 |
| $86,713 | $81,414 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.